The store will not work correctly when cookies are disabled.
5-tert-Butyl-6-chloro-N-p-tolylpyrazine-2-carboxamide
ID: ALA448573
PubChem CID: 24881801
Max Phase: Preclinical
Molecular Formula: C16H18ClN3O
Molecular Weight: 303.79
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(NC(=O)c2cnc(C(C)(C)C)c(Cl)n2)cc1
Standard InChI: InChI=1S/C16H18ClN3O/c1-10-5-7-11(8-6-10)19-15(21)12-9-18-13(14(17)20-12)16(2,3)4/h5-9H,1-4H3,(H,19,21)
Standard InChI Key: XHEOBPLQFLPUDK-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
5.2194 0.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2182 0.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9331 -0.2444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6495 0.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6466 0.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9313 1.4086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3596 1.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0756 1.0049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3564 2.2397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7885 1.4201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5029 1.0068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2153 1.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2127 2.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4916 2.6568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7822 2.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5035 -0.2434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7833 -0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9122 -0.9600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0964 0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5048 1.4082 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.9250 2.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
2 16 1 0
7 8 1 0
16 17 1 0
16 18 1 0
7 9 2 0
16 19 1 0
4 5 1 0
1 20 1 0
8 10 1 0
13 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.79 | Molecular Weight (Monoisotopic): 303.1138 | AlogP: 3.99 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.98 | CX Basic pKa: ┄ | CX LogP: 4.28 | CX LogD: 4.28 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.91 | Np Likeness Score: -1.61 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |